With recent advancements in medical treatments for metastatic renal cell carcinoma (mRCC), increased treatment efficiency may also come with increased toxicity. In this podcast, authors discuss the appropriate management of the adverse events that result from drug toxicity in order to achieve optimal oncological outcomes for their patients whilst still maintaining their quality of life.
12-07-2023 | Podcast | Article | Supported by: Eisai Europe Limited
Navigating the treatment of renal cell carcinoma: Insights on the current treatment landscape and managing patient health
Guests:
Dr. Philipp Ivanyi
Prof. Viktor Grünwald
Host:
Lydia Alborn